BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 29, 2011
 |  BC Week In Review  |  Company News  |  Deals

Halo-Bio RNAi Therapeutics Inc., Tekmira deal

Halo-Bio granted Tekmira exclusive, worldwide rights to multivalent RNAi (MV-RNA) technology. The partners will design and develop MV-RNA molecules against undisclosed gene...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >